Renal artery stenosis evaluation in chronic kidney disease patients : Nonenhanced time-spatial labeling inversion-pulse threedimensional MR angiography with regulated breathing versus DSA

Radiology

Volumn 259, Issue 2, 2011, Pages 592-601

  Parienty, Isabelle ^a   Rostoker, Guy ^b   Jouniaux, Francis ^a   Piotin, Michel ^b   Admiraal Behloul, Faiza ^c   Miyazaki, Mitsue ^d  

^a Pédiatrie Surgery Unit   (France)

^b INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

^c Toshiba Medical Systems Europe   (Netherlands)

^d Toshiba Medical Research Institute USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODIXANOL;

ADULT; AGED; ARTICLE; BREATHING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; KIDNEY ARTERY STENOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL ARTERY OBSTRUCTION; RENAL INSUFFICIENCY, CHRONIC; STATISTICS, NONPARAMETRIC;

EID: 79955039862     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11101422     Document Type: Article

References (37)

1. Dworkin LD , Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med 2009 ; 361 (20): 1972-1978.
2. Gilfeather M , Yoon HC , Siegelman ES , et al. Renal artery stenosis: Evaluation with con ventional angiography versus gadoliniumenhanced MR angiography. Radiology 1999 ; 210 (2): 367-372. (Pubitemid 29055302)
3. Mittal TK , Evans C , Perkins T , Wood AM. Renal arteriography using gadolinium enhanced 3D MR angiography: Clinical experience with the technique, its limitations and pitfalls. Br J Radiol 2001 ; 74 (882): 495-502. (Pubitemid 32674210)
4. Schoenberg SO , Knopp MV , Londy F , et al. Morphologic and functional magnetic resonance imaging of renal artery stenosis: A multireader tricenter study. J Am Soc Nephrol 2002 ; 13 (1): 158-169. (Pubitemid 34042023)
5. Schoenberg SO , Rieger J , Weber CH , et al. High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: Comparison with digital subtraction angiography and US. Radiology 2005 ; 235 (2): 687-698. (Pubitemid 40571115)
6. Shellock FG , Hahn HP , Mink JH , Itskovich E. Adverse reaction to intravenous gadoteridol. Radiology 1993 ; 189 (1): 151-152. (Pubitemid 23292939)
7. Jordan RM , Mintz RD. Fatal reaction to gadopentetate dimeglumine. AJR Am J Roentgenol 1995 ; 164 (3): 743-744.
8. Witte RJ , Anzai LL. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine. AJNR Am J Neuroradiol 1994 ; 15 (3): 523-524. (Pubitemid 24089545)
9. Unal O, Arslan H. Cardiac arrest caused by IV gadopentetatedimeglumine [letter]. AJR Am J Roentgenol 1999 ; 172 : 1141. (Pubitemid 29505661)
10. Tishler S , Hoffman JC Jr. Anaphylactoid reactions to i.v. gadopentetate dimeglumine [letter]. AJNR Am J Neuroradiol 1990 ; 11 (6): 1167 ; discussion 1168-1169. (Pubitemid 20359028)
11. U.S. Food and Drug Administration. Public health advisory: Update on magnetic resonance imaging (MRI) contrast agents containing gadolinium and nephrogenic fibrosing dermopathy. http://www.fda.gov/Drugs/Drug Safety/PublicHealthAdvisories/ucm124344. htm. Published December 22, 2006. Updated May 23, 2007. Accessed 2007.
12. Morcos SK , Thomsen HS. Nephrogenic systemic fibrosis: More questions and some answers. Nephron Clin Pract 2008 ; 110 (1): C24 - c31; discussion c32.
13. Kanal E , Barkovich J , Bell C , et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 2007 ; 188 (6): 1447-1474. (Pubitemid 46866845)
14. Roditi G , Maki JH , Oliveira G , Michaely HJ. Renovascular imaging in the NSF era. J Magn Reson Imaging 2009 ; 30 (6): 1323-1334.
15. Broome DR. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting. Eur J Radiol 2008 ; 66 (2): 230-234.
16. Collidge TA , Thomson PC , Mark PB , et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort. Radiology 2007 ; 245 (1): 168-175. (Pubitemid 47417800)
17. Bhave G , Lewis JB , Chang SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol 2008 ; 180 (3): 830 - 835; discussion 835.
18. Prince MR , Zhang HL , Prowda JC , Grossman ME , Silvers DN. Nephrogenic systemic fibrosis and its impact on abdominal imaging. RadioGraphics 2009 ; 29 (6): 1565-1574.
19. Loubeyre P , Revel D , Garcia P , et al. Screening patients for renal artery stenosis: Value of three-dimensional time-of-fl ight MR angiography. AJR Am J Roentgenol 1994 ; 162 (4): 847-852. (Pubitemid 24115869)
20. Duda SH , Schick F , Teufl F , et al. Phasecontrast MR angiography for detection of arteriosclerotic renal artery stenosis. Acta Radiol 1997 ; 38 (2): 287-291. (Pubitemid 127452175)
21. Katoh M , Spuentrup E , Stuber M , Hoogeveen R , Günther RW , Buecker A. Free-breathing renal magnetic resonance angiography with steady-state free-precession and slabselective spin inversion combined ith radial k-space sampling and water-selective excitation. Magn Reson Med 2005 ; 53 (5): 1228-1233. (Pubitemid 40627805)
22. Herborn CU , Watkins DM , Runge VM , Gendron JM , Montgomery ML , Naul LG. Renal arteries: Comparison of steady-state free precession MR angiography and contrastenhanced MR angiography. Radiology 2006 ; 239 (1): 263-268.
23. Wyttenbach R , Braghetti A , Wyss M , et al. Renal artery assessment with nonenhanced steady-state free precession versus contrastenhanced MR angiography. Radiology 2007 ; 245 (1): 186-195. (Pubitemid 47417802)
24. Maki JH , Wilson GJ , Eubank WB , Glickerman DJ , Millan JA , Hoogeveen RM. Navigatorgated MR angiography of the renal arteries: A potential screening tool for renal artery stenosis. AJR Am J Roentgenol 2007 ; 188 (6): W540-W546.
25. Maki JH , Wilson GJ , Eubank WB , Glickerman DJ , Pipavath S , Hoogeveen RM. Steady-state free precession MRA of the renal arteries: Breath-hold and navigatorgated techniques vs. CE-MRA. J Magn Reson Imaging 2007 ; 26 (4): 966-973. (Pubitemid 47548158)
26. Utsunomiya D , Miyazaki M , Nomitsu Y , et al. Clinical role of non-contrast magnetic resonance angiography for evaluation of renal artery stenosis. Circ J 2008 ;72 (10): 1627-1630.
27. Stafford RB , Sabati M , Haakstad MJ , Mahallati H , Frayne R. Unenhanced MR angiography of the renal arteries with balanced steadystate free precession dixon method. AJR Am J Roentgenol 2008 ; 191 (1): 243-246. (Pubitemid 351955202)
28. Miyazaki M , Lee VS. Nonenhanced MR angiography. Radiology 2008 ; 248 (1): 20-43.
29. Lanzman RS , Voiculescu A , Walther C , et al. ECG-gated nonenhanced 3D steady-state free precession MR angiography in assessment of transplant renal arteries: Comparison with DSA. Radiology 2009 ; 252 (3): 914-921.
30. Cockcroft DW , Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 ; 16 (1): 31-41.
31. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002 ; 39 (2 suppl 1): S1-S266.
32. Takahashi J , Tsuji Y , Hamada Y , et al. Noncontrast enhanced renal MRA using timespatial labeling pulse (t-SLIP) with 3D balanced SSFP [abstr]. In: Proceedings of the Fifteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2007 ; 179.
33. Jouniaux F , Parienty I , Admiraal-Behloul F. Respiratory rate regulation for optimal time- SLIP imaging of renal arteries [abstr]. In: Proceedings of the Eighteenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2010 ; 3770.
34. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ : Lawrence Erlbaum Associates , 1988.
35. Patel ST , Mills JL Sr , Tynan-Cuisinier G , Goshima KR , Westerband A , Hughes JD. The limitations of magnetic resonance angiography in the diagnosis of renal artery stenosis: Comparative analysis with conventional arteriography. J Vasc Surg 2005 ; 41 (3): 462-468. (Pubitemid 40523590)
36. Shonai T , Takahashi T , Ikeguchi H , Miyazaki M , Amano K , Yui M. Improved arterial visibility using short-tau inversion-recovery (STIR) fat suppression in non-contrast-enhanced time-spatial labeling inversion pulse (Time- SLIP) renal MR angiography (MRA). J Magn Reson Imaging 2009 ; 29 (6): 1471-1477.
37. Lanzman RS , Kröpil P , Schmitt P , Freitag SM , Ringelstein Wittsack HJ , Blondin D. Nonenhanced free-breathing ECG-gated steady-state free precession 3D MR angiography of the renal arteries: Comparison between 1.5 T and 3 T. AJR Am J Roentgenol 2010 ; 194 (3): 794-798.